Ludwig Institute for Cancer Research

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ludwig Institute for Cancer Research.The latest application filed is for "compounds and methods for increasing stmn2 expression".

Company Profile

11.200.105

Ludwig Institute for Cancer Research - New York NY US
Ludwig Institute For Cancer Research - Zurich CH
Ludwig Institute for Cancer Research -
Ludwig Institute for Cancer Research - BE BE
LUDWIG INSTITUTE FOR CANCER RESEARCH - Abbott Park IL
Ludwig Institute for Cancer Research - Brussels BE
LUDWIG INSTITUTE FOR CANCER RESEARCH - VICTORIA AU
Ludwig Institute for Cancer Research - Helsinki FI
Ludwig Institute for Cancer Research - Stadelhoferstrasse CH
Ludwig Institute For Cancer Research - 605 Third Avenue New York NY
Ludwig Institute for Cancer Research - London GB
LUDWIG INSTITUTE FOR CANCER RESEARCH - 605 Third Avenue 33rd Floor New York NY
Ludwig Institute for Cancer Research - Parkville AU
Ludwig Institute for Cancer Research - Sao Paulo BR
Ludwig Institute for Cancer Research - 605 Avenue of the Americas New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Methods for modulating expression of C9ORF72 antisense transcript Grant 11,162,096 - Bennett , et al. November 2, 2	2021-11-02
Compounds And Methods For Increasing Stmn2 Expression App 20210252039 - Bui; Huynh-Hoa ; et al.	2021-08-19
Products and Methods for Treatment of Familial Amyotrophic Lateral Sclerosis App 20210108209 - Kaspar; Brian K. ; et al.	2021-04-15
Products and methods for treatment of familial amyotrophic lateral sclerosis Grant 10,793,861 - Kaspar , et al. October 6, 2	2020-10-06
iNKT cell modulators and methods of using the same Grant 10,765,648 - Cerundolo , et al. Sep	2020-09-08
Modified Crispr Rna And Uses Thereof App 20190382751 - Radhar; Meghdad ; et al.	2019-12-19
Whole-genome and targeted haplotype reconstruction Grant 10,508,303 - Ren , et al. Dec	2019-12-17
Inkt Cell Modulators And Methods Of Using The Same App 20190374486 - Cerundolo; Vincenzo ; et al.	2019-12-12
iNKT cell modulators and methods of using the same Grant 10,314,796 - Cerundolo , et al.	2019-06-11
Products and Methods for Treatment of Familial Amyotrophic Lateral Sclerosis App 20190144868 - Kaspar; Brian K. ; et al.	2019-05-16
Methods For Reducing C9orf72 Expression App 20190142856A1 -	2019-05-16
Methods and compositions for cDNA synthesis and single-cell transcriptome profiling using template switching reaction Grant 10,266,894 - Sandberg , et al.	2019-04-23
Methods for prognosis prediction for melanoma cancer Grant 10,266,902 - Black , et al.	2019-04-23
Methods For Modulating Expression Of C9orf72 Antisense Transcript App 20180142240 - Bennett; C. Frank ; et al.	2018-05-24
Methods for modulating C9ORF72 expression Grant 9,963,699 - Bennett , et al. May 8, 2	2018-05-08
Detection of EphA3 as a Marker of the Presence of a Solid Tumor App 20170335001 - Lackmann; Martin ; et al.	2017-11-23
iNKT cell modulators and methods of using the same Grant 9,700,532 - Cerundolo , et al. July 11, 2	2017-07-11
TRUNCATED VARIANT OF THE MAMMALIAN TARGET FOR RAPAMYCIN (mTOR) PROTEIN App 20170145391 - Nemazanyy; Ivan ; et al.	2017-05-25
Specific binding proteins and uses thereof Grant 9,562,102 - Old , et al. February 7, 2	2017-02-07
Devices and methods for prognosis prediction for melanoma cancer Grant 9,534,258 - Black , et al. January 3, 2	2017-01-03
Inkt Cell Modulators And Methods Of Using The Same App 20160361280 - Cerundolo; Vincenzo ; et al.	2016-12-15
Methods and compositions for modulation of blood-neural barrier Grant 9,487,579 - Eriksson , et al. November 8, 2	2016-11-08
NY-ESO-1 peptides which bind to class II molecules and uses thereof Grant 9,469,678 - Pfreudschuh , et al. October 18, 2	2016-10-18
Products And Methods For Treatment Of Familial Amyotrophic Lateral Sclerosis App 20160272976 - Kaspar; Brian K. ; et al.	2016-09-22
METHODS AND COMPOSITIONS FOR cDNA SYNTHESIS AND SINGLE-CELL TRANSCRIPTOME PROFILING USING TEMPLATE SWITCHING REACTION App 20160258016 - Sandberg; Rickard ; et al.	2016-09-08
iNKT cell modulators and methods of using the same Grant 9,365,496 - Cerundolo , et al. June 14, 2	2016-06-14
In Vivo Efficacy Of Ny-eso-1 Plus Adjuvant App 20160000894 - Cebon; Jonathan ; et al.	2016-01-07
Antibodies directed to the receptor tyrosine kinase c-Met Grant 9,169,329 - Johns , et al. October 27, 2	2015-10-27
Methods For Modulating C9orf72 Expression App 20150267197 - Bennett; C. Frank ; et al.	2015-09-24
Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases Grant 9,078,877 - Eriksson July 14, 2	2015-07-14
Method for modulating activity of T lymphocytes Grant 8,951,747 - Demotte , et al. February 10, 2	2015-02-10
Devices And Methods For Prognosis Prediction For Melanoma Cancer App 20150031578 - BLACK; MICHAEL ALAN ; et al.	2015-01-29
Methods And Compositions For Modulation Of Blood-neural Barrier App 20140255397 - Eriksson; Ulf ; et al.	2014-09-11
Immunogenic Compositions Useful In Provoking An Integrated Response To Tumor Antigens App 20140255436 - TSUJI; Takemasa ; et al.	2014-09-11
Cell-type-specific patterns of gene expression Grant 8,781,750 - Stuart , et al. July 15, 2	2014-07-15
Methods and compositions for modulation of blood-neural barrier Grant 8,765,671 - Eriksson , et al. July 1, 2	2014-07-01
TRUNCATED VARIANT OF THE MAMMALIAN TARGET FOR RAPAMYCIN (mTOR) PROTEIN App 20140120099 - Nemazanyy; Ivan ; et al.	2014-05-01
Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein Grant 8,541,202 - Knuth , et al. September 24, 2	2013-09-24
CTSP cancer-testis antigens Grant 8,470,989 - Parmigiani , et al. June 25, 2	2013-06-25
Targeting Vegf-b Regulation Of Fatty Acid Transporters To Modulate Human Diseases App 20130156757 - Eriksson; Ulf	2013-06-20
A34 and A33-like 3 DNA protein, antibodies thereto and methods of treatment using same Grant 8,440,807 - Scanlan , et al. May 14, 2	2013-05-14
Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases Grant 8,383,112 - Eriksson February 26, 2	2013-02-26
Methods for stimulating an immune response using bacterial antigen delivery system Grant 8,357,373 - Old , et al. January 22, 2	2013-01-22
Method for determining presence of cancer in a sample by assaying for expression of ECSA/DPPA-2 nucleotide sequences Grant 8,354,243 - John , et al. January 15, 2	2013-01-15
Analogs of alpha galactosylceramide and uses thereof Grant 8,334,408 - Cerundolo , et al. December 18, 2	2012-12-18
Analogs Of Alpha Galactosylceramide And Uses Thereof App 20120269857 - CERUNDOLO; Vincenzo ; et al.	2012-10-25
Immunogenic polypeptides encoded by MAGE minigenes and uses thereof Grant 8,257,717 - Berinstein , et al. September 4, 2	2012-09-04
Human sarcoma-associated antigens Grant 8,252,903 - Scanlan , et al. August 28, 2	2012-08-28
Tumor associated amino acids and uses therefor Grant 8,247,379 - Martelange , et al. August 21, 2	2012-08-21
Method For Modulating Activity Of T Lymphocytes App 20120196363 - DEMOTTE; Nathalie ; et al.	2012-08-02
Specific Binding Proteins And Uses Thereof App 20120183471 - Old; Lloyd J. ; et al.	2012-07-19
In Vivo Efficacy Of Ny-eso-1 Plus Adjuvant App 20120171232 - Cebon; Jonathan ; et al.	2012-07-05
Methods And Compositions For Modulation Of Blood-neural Barrier App 20120156187 - Eriksson; Ulf ; et al.	2012-06-21
Analogs of alpha galactosylceramide and uses thereof Grant 8,188,313 - Cerundolo , et al. May 29, 2	2012-05-29
Targeting Vegf-b Regulation Of Fatty Acid Transporters To Modulate Human Diseases App 20120114642 - ERIKSSON; ULF	2012-05-10
Tame based chelators and uses thereof Grant 8,173,102 - Arslantas , et al. May 8, 2	2012-05-08
Methods and compositions for modulation of blood-neural barrier Grant 8,147,828 - Eriksson , et al. April 3, 2	2012-04-03
Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein Grant 8,142,786 - Knuth , et al. March 27, 2	2012-03-27
MAGE-C2 antigenic peptides and uses thereof Grant 8,143,011 - Ma , et al. March 27, 2	2012-03-27
A34 And A33-like 3 Dna Protein, Antibodies Thereto And Methods Of Treatment Using Same App 20120039892 - Scanlan; Matthew ; et al.	2012-02-16
Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases Grant 8,114,399 - Eriksson February 14, 2	2012-02-14
Antibodies which bind specifically to activin receptor like kinase 3 Grant 8,080,639 - Miyazono , et al. December 20, 2	2011-12-20
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 8,071,717 - Jager , et al. December 6, 2	2011-12-06
Fused heteroaryl derivatives Grant 8,067,586 - Hayakawa , et al. November 29, 2	2011-11-29
Analogs of alpha galactosyceramide and uses thereof Grant 8,039,670 - Cerundolo , et al. October 18, 2	2011-10-18
Methods For The Treatment Of Cancer App 20110229469 - Johns; Terrance	2011-09-22
Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use Grant 8,012,704 - Miyazono , et al. September 6, 2	2011-09-06
Cancer-testis antigens App 20110177079 - Chen; Yao-Tseng ; et al.	2011-07-21
Glial mitogenic factors, their preparation and use Grant 7,968,678 - Goodearl , et al. June 28, 2	2011-06-28
Regulation Of Fatty Acid Transporters App 20110150900 - Eriksson; Ulf	2011-06-23
Activin receptor-like kinase-1 proteins having serine-threonine kinase domains Grant 7,932,351 - Miyazono , et al. April 26, 2	2011-04-26
Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3 Grant 7,923,534 - Boon , et al. April 12, 2	2011-04-12
Specific Binding Proteins And Uses Thereof App 20110076232 - Old; Lloyd J. ; et al.	2011-03-31
Humanized GM-CSF antibodies Grant 7,897,743 - Renner , et al. March 1, 2	2011-03-01
Isolated nucleic acid molecules which encode immunogenic portions of NY-ESO-1 protein Grant 7,888,100 - Knuth , et al. February 15, 2	2011-02-15
SSX-4 peptides presented by HLA class II molecules Grant 7,858,743 - Valmori , et al. December 28, 2	2010-12-28
Immunogenic polypeptides encoded by MAGE minigenes and uses thereof Grant 7,851,212 - Berinstein , et al. December 14, 2	2010-12-14
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 7,795,379 - Jager , et al. September 14, 2	2010-09-14
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof Grant 7,795,409 - Jager , et al. September 14, 2	2010-09-14
MAGE-C2 antigenic peptides and uses thereof Grant 7,785,881 - Van Pel , et al. August 31, 2	2010-08-31
Tame based chelators and uses thereof Grant 7,780,947 - Arslantas , et al. August 24, 2	2010-08-24
Peptide inhibitors of IASPP Grant 7,745,571 - Lu , et al. June 29, 2	2010-06-29
Fusion proteins of humanized g250 specific antibodies and uses thereof Grant 7,714,113 - Renner , et al. May 11, 2	2010-05-11
Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof Grant 7,713,714 - Valmori , et al. May 11, 2	2010-05-11
Stimulation of vascularization with VEGF-B-186 Grant 7,709,450 - Eriksson , et al. May 4, 2	2010-05-04
Pharmaceutical compounds Grant 7,696,204 - McDonald , et al. April 13, 2	2010-04-13
Human sarcoma-associated antigens Grant 7,662,917 - Scanlan , et al. February 16, 2	2010-02-16
Tumour suppressor protein Grant 7,645,859 - Lu , et al. January 12, 2	2010-01-12
Targeting VEGF-B Regulation Of Fatty Acid Transporters To Modulate Human Diseases App 20090324611 - Eriksson; Ulf	2009-12-31
Methods for Stimulating an Immune Response Using Bacterial Antigen Delivery System App 20090324651 - Old; Lloyd J. ; et al.	2009-12-31
Identification of new NY-ESO-1 epitopes recognized by CD4+ T-cells Grant 7,632,506 - Jager December 15, 2	2009-12-15
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 7,622,568 - Jager , et al. November 24, 2	2009-11-24
A34 And A33-like 3 Dna Protein, Antibodies Thereto And Methods Of Treatment Using Same App 20090263394 - Scanlan; Matthew ; et al.	2009-10-22
Antibodies which bind specifically to activin receptor like kinases Grant 7,592,428 - Miyazono , et al. September 22, 2	2009-09-22
Specific binding proteins and uses thereof App 20090220510 - Old; Lloyd J. ; et al.	2009-09-03
Methods and compositions for regulating cell cycle checkpoints App 20090214524 - Kops; Geert J. P. L. ; et al.	2009-08-27
Mage-a3 Peptides Presented By Hla-dr1 Molecules App 20090203124 - Zhang; Yi ; et al.	2009-08-13
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof App 20090203123 - Jager; Dirk ; et al.	2009-08-13
Isolated GAGE-7B and 8 proteins Grant 7,572,885 - De Backer , et al. August 11, 2	2009-08-11
Human sarcoma-associated antigens Grant 7,560,537 - Scanlan , et al. July 14, 2	2009-07-14
Tumor rejection antigens Grant 7,547,439 - Huang , et al. June 16, 2	2009-06-16
MAGE-C2 antigenic peptides and uses thereof Grant 7,547,517 - Ma , et al. June 16, 2	2009-06-16
Glial mitogenic factors, their preparation and use Grant 7,541,338 - Goodearl , et al. June 2, 2	2009-06-02
A34 and A33-like 3 DNA, proteins, antibodies thereto and methods of treatment using same Grant 7,521,543 - Scanlan, legal representative , et al. April 21,	2009-04-21
Fixed Charge Reagents App 20090053817 - Reid; Gavin E. ; et al.	2009-02-26
Isolated proteins MAGE-4 and MAGE-41 Grant 7,495,074 - Guagler , et al. February 24, 2	2009-02-24
Methods and compositions for PDGF-C activation and inhibition App 20090047284 - Fredriksson; Linda ; et al.	2009-02-19
Methods and Compositions For PDGF-D Activation and Inhibition App 20090041755 - Eriksson; Ulf	2009-02-12
Isolated peptide which binds to HLA-Cw*07 and uses thereof Grant 7,488,793 - Van Der Bruggen , et al. February 10, 2	2009-02-10
Method for modulating, regulating and/or stabilizing angiogenesis Grant 7,476,654 - Alitalo , et al. January 13, 2	2009-01-13
Tumor Associated Amino Acids And Uses Therefor App 20080299078 - Martelange; Valerie ; et al.	2008-12-04
Peptide Inhibitors of iASPP App 20080260756 - Lu; Xin ; et al.	2008-10-23
SSX-2 peptides presented by HLA class II molecules Grant 7,429,639 - Ayyoub , et al. September 30, 2	2008-09-30
Colon cancer antigen panel App 20080226664 - Old; Lloyd J. ; et al.	2008-09-18
Method for determining modulation of P110.DELTA. activity Grant 7,422,886 - Vanhasebroeck , et al. September 9, 2	2008-09-09
Method for determining expression of a PI3 kinase gene Grant 7,422,849 - Hiles , et al. September 9, 2	2008-09-09
Variant Polypeptide and Screening Assay App 20080193488 - Lu; Xin	2008-08-14
Tumor associated nucleic acids and uses therefor Grant 7,411,042 - Martelange , et al. August 12, 2	2008-08-12
Ny-Eso-1 Peptides Which Bind To Class II Molecules And Uses Thereof App 20080187548 - Pfreudschuh; Michael ; et al.	2008-08-07
Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use App 20080145366 - Achen; Marc G. ; et al.	2008-06-19
MAGE peptides presented by HLA class II molecules Grant 7,388,072 - Zhang , et al. June 17, 2	2008-06-17
Isolated peptides which bind to MHC Class II molecules, and uses thereof Grant 7,385,044 - Tureci , et al. June 10, 2	2008-06-10
Chimerized GM-CSF antibodies Grant 7,381,801 - Renner , et al. June 3, 2	2008-06-03
MAGE-A3 peptides presented by HLA class II molecules Grant 7,371,845 - Zhang , et al. May 13, 2	2008-05-13
Recombinant anti-interleukin-9 antibodies Grant 7,371,383 - Reed , et al. May 13, 2	2008-05-13
Human Sarcoma-Associated Antigens App 20080089888 - Scanlan; Matthew J. ; et al.	2008-04-17
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 7,354,992 - Jager , et al. April 8, 2	2008-04-08
Tumor antigens and CTL clones isolated by a novel procedure Grant 7,351,409 - Chaux , et al. April 1, 2	2008-04-01
Mage C2 antigenic peptides and uses thereof Grant 7,348,007 - Pel , et al. March 25, 2	2008-03-25
Isolated nucleic acid molecules which encode peptides that bind to HLA molecules, and uses thereof Grant 7,344,879 - Valmori , et al. March 18, 2	2008-03-18
Processed vascular endothelial growth factor-B polypeptides Grant 7,341,996 - Eriksson , et al. March 11, 2	2008-03-11
Growth Factor App 20080058258 - Achen; Marc G. ; et al.	2008-03-06
Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins App 20080058263 - Alitalo; Kari ; et al.	2008-03-06
Breast cancer antigens Grant 7,335,467 - Scanlan , et al. February 26, 2	2008-02-26
Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor Grant RE40,089 - Boon-Falleur , et al. February 19, 2	2008-02-19
Glial mitogenic factors lacking an N-terminal signal sequence Grant 7,319,019 - Goodearl , et al. January 15, 2	2008-01-15
Small cell lung cancer associated antigens and uses therefor Grant 7,314,721 - Gure , et al. January 1, 2	2008-01-01
Vascular Endothelial Growth Factor D(VEGF-D) Antibodies and Vectors, and Methods of Uses App 20070298493 - Achen; Marc G. ; et al.	2007-12-27
MAGE-A4 antigenic peptides and uses thereof Grant 7,311,914 - Zhang , et al. December 25, 2	2007-12-25
Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins Grant 7,309,604 - Alitalo , et al. December 18, 2	2007-12-18
Methods And Compositions For Modulation Of Blood-neural Barrier App 20070265203 - Eriksson; Ulf ; et al.	2007-11-15
Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof Grant 7,291,335 - Stockert , et al. November 6, 2	2007-11-06
Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor Grant 7,285,531 - Goodearl , et al. October 23, 2	2007-10-23
Methods for Inhibiting Angiogenesis and/or Lymphangiogenesis App 20070224194 - McColl; Bradley ; et al.	2007-09-27
Isolated nucleic acid molecules encoding isolated peptides which correspond to contiguous amino acids of an SSX molecule or NY-ESO-1 and uses thereof Grant 7,270,819 - Tureci , et al. September 18, 2	2007-09-18
Protease-resistant forms of VEGF-D, method of making and method of use App 20070212390 - Paavonen; Karri ; et al.	2007-09-13
Method for generating an immune response and reagents therefor Grant 7,259,235 - Old , et al. August 21, 2	2007-08-21
MAGE-3 peptides presented by HLA class II molecules Grant 7,252,825 - Chaux , et al. August 7, 2	2007-08-07
Screening and Therapy for Lymphatic Disorders Involving the FLT4 Receptor Tyrosine Kinase (VEGFR-3) App 20070141609 - Ferrell; Robert E. ; et al.	2007-06-21
Modified VEGF-A with improved angiogenic properties App 20070142282 - Alitalo; Kari ; et al.	2007-06-21
Breast, gastric and prostate cancer associated antigens and uses therefor App 20070128655 - Obata; Yuichi	2007-06-07
Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-4 and 41 and uses thereof Grant 7,199,231 - Guagler , et al. April 3, 2	2007-04-03
Methods for treating multiple sclerosis with GGF-related polypeptides Grant 7,192,915 - Goodearl , et al. March 20, 2	2007-03-20
Platelet-derived growth factor D, DNA coding therefor, and uses thereof App 20070042413 - Eriksson; Ulf ; et al.	2007-02-22
Fused heteroaryl derivatives Grant 7,173,029 - Hayakawa , et al. February 6, 2	2007-02-06
Breast, gastric and prostate cancer associated antigens and uses therefor Grant 7,166,573 - Obata January 23, 2	2007-01-23
Vascular endothelial growth factor polypeptides Grant 7,160,991 - Hayward , et al. January 9, 2	2007-01-09
MAGE-A1 peptides presented by HLA class II molecules Grant 7,157,091 - Van Snick , et al. January 2, 2	2007-01-02
A34 and a33-Like 3dna, proteins, antibodies thereto and methods of treatment using same App 20060292154 - Scanlan; Matthew ; et al.	2006-12-28
Platelet-derived growth factor D, DNA coding therefor, and uses thereof Grant 7,148,037 - Eriksson , et al. December 12, 2	2006-12-12
Glial mitogenic factors, their preparation and use Grant 7,135,456 - Goodearl , et al. November 14, 2	2006-11-14
Isolated cancer associated antigens NY-MEL 1 and NY-MEL 3, peptides based thereon, and their uses Grant 7,132,507 - Jager , et al. November 7, 2	2006-11-07
Progenitor cell materials and methods Grant 7,125,714 - Alitalo , et al. October 24, 2	2006-10-24
Methods for detection of disease-associated antibodies in urine Grant 7,125,681 - Knuth , et al. October 24, 2	2006-10-24
Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use Grant 7,122,654 - Achen , et al. October 17, 2	2006-10-17
Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53 Grant 7,115,729 - Knuth , et al. October 3, 2	2006-10-03
Method for stimulating connective tissue growth or wound healing Grant 7,105,481 - Uutela , et al. September 12, 2	2006-09-12
Antibodies to truncated VEGF-D and uses thereof Grant 7,097,986 - Achen , et al. August 29, 2	2006-08-29
Isolated nucleic acid molecules which encode a soluble IL-TIF/IL-22 receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof Grant 7,094,570 - Renauld , et al. August 22, 2	2006-08-22
Glial mitogenic factors, their preparation and use Grant 7,094,749 - Goodearl , et al. August 22, 2	2006-08-22
Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use App 20060177428 - Achen; Marc G. ; et al.	2006-08-10
Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy App 20060177901 - Alitalo; Kari ; et al.	2006-08-10
Isolated nucleic acid molecules encoding T cell derived inducible factors Grant 7,081,528 - Dumoutier , et al. July 25, 2	2006-07-25
Vector-mediated delivery of polynucleotides encoding soluble VEGF receptors App 20060110364 - Harding; Thomas	2006-05-25
MAGE-A3 peptides presented by HLA class II molecules Grant 7,049,413 - Zhang , et al. May 23, 2	2006-05-23
Methods and compositions for PDGF-C activation and inhibition App 20060104978 - Fredriksson; Linda ; et al.	2006-05-18
VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor Grant 7,045,133 - Achen , et al. May 16, 2	2006-05-16
Isolated peptides which bind to HLA-B18 molecules and uses thereof Grant 7,041,502 - Bilsborough , et al. May 9, 2	2006-05-09
Method for analysing amino acids, peptides and proteins App 20060094121 - Reid; Gavin ; et al.	2006-05-04
Fused heteroaryl derivatives Grant 7,037,915 - Hayakawa , et al. May 2, 2	2006-05-02
Cancer-testis antigens App 20060089303 - Old; Lloyd J. ; et al.	2006-04-27
FLT4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy Grant 7,034,105 - Alitalo , et al. April 25, 2	2006-04-25
Non-human transgenic animals expressing platelet-derived growth factor C (PDGF-C) and uses thereof Grant 7,034,200 - Eriksson , et al. April 25, 2	2006-04-25
Isolated cytokine receptor LICR-2 Grant 7,033,787 - Renauld , et al. April 25, 2	2006-04-25
Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereof Grant 7,022,819 - Lucas , et al. April 4, 2	2006-04-04
SSX-4 peptides presented by HLA class II molecules App 20060051772 - Valmori; Danila ; et al.	2006-03-09
Isolated peptides which bind to HLA-C molecules and uses thereof Grant 7,009,035 - Gnjatic , et al. March 7, 2	2006-03-07
Tumor associated nucleic acids and uses therefor Grant 7,001,999 - Martelange , et al. February 21, 2	2006-02-21
Antibosies to PDGF-D App 20060030695 - Uutela; Marko ; et al.	2006-02-09
Growth factor binding constructs materials and methods App 20060030000 - Alitalo; Kari ; et al.	2006-02-09
Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same App 20060024302 - Achen; Marc Gregory ; et al.	2006-02-02
Tumor associated nucleic acids and uses therefor App 20060024742 - Martelange; Valerie ; et al.	2006-02-02
Compositions and methods for treatment of lymphatic and venous vessel arterialization App 20060025338 - Alitalo; Kari ; et al.	2006-02-02
Isolated nucleic acid molecules associated with colon cancer and methods for diagnosing and treating colon cancer Grant 6,982,316 - Scanlan , et al. January 3, 2	2006-01-03
Antibodies which bind specifically to activin receptor-like kinases Grant 6,982,319 - Miyazono , et al. January 3, 2	2006-01-03
Methods and compositions for activating or inhibiting vegf-d and vegf-c App 20050282228 - Mccoll, Bradley ; et al.	2005-12-22
Multivalent antibody materials and methods for VEGF/PDGF family of growth factors App 20050282233 - Eriksson, Ulf ; et al.	2005-12-22
Methods for inhibiting angiogenesis and or lymphangiogenesis App 20050272664 - McColl, Bradley ; et al.	2005-12-08
Glial mitogenic factors, their preparation and use Grant 6,972,280 - Goodearl , et al. December 6, 2	2005-12-06
Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins App 20050267024 - Alitalo, Kari ; et al.	2005-12-01
Method for modulating, regulating and/or stabilizing angiogenesis App 20050260161 - Alitalo, Karl ; et al.	2005-11-24
Differential drug sensitivity App 20050260629 - Lu, Xin	2005-11-24
Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins Grant 6,965,010 - Alitalo , et al. November 15, 2	2005-11-15
Methods for detecting for the presence of tumor cells and for screening for anti-tumor agents App 20050250103 - Li, Xuri ; et al.	2005-11-10
Method for inhibiting tumor formation and growth App 20050214280 - Li, Xuri ; et al.	2005-09-29
Method for stimulating connective tissue growth or wound healing App 20050209136 - Eriksson, Ulf ; et al.	2005-09-22
Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-6 and uses thereof Grant 6,946,289 - Guagler , et al. September 20, 2	2005-09-20
Truncated EGF receptor Grant 6,946,543 - Ward , et al. September 20, 2	2005-09-20
Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue App 20050202015 - Achen, Marc ; et al.	2005-09-15
Isolated nucleic acid molecules which encode GAGE genes and uses thereof Grant 6,939,707 - van der Bruggen , et al. September 6, 2	2005-09-06
Method of designing agonists and antagonists to EGF receptor family Grant 6,941,229 - Elleman , et al. September 6, 2	2005-09-06
Identification and functional characterization of a novel ribosomal S6 protein kinase App 20050158748 - Gout, Ivan ; et al.	2005-07-21
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 6,911,529 - Jager , et al. June 28, 2	2005-06-28
TGFbeta signaling inhibitors App 20050136043 - Yakymovych, Ihor ; et al.	2005-06-23
Assay and treatment App 20050123977 - Lu, Xin	2005-06-09
Mage-A12 antigenic peptides and uses thereof Grant 6,897,288 - Heidecker , et al. May 24, 2	2005-05-24
SSX-2 peptides presented by HLA class II molecules App 20050079553 - Ayyoub, Maha ; et al.	2005-04-14
Method for determining modulation of p110.delta. activity Grant 6,849,420 - Vanhasebroeck , et al. February 1, 2	2005-02-01
Isolated proteins containing portions of FAP.alpha. and other proteins Grant 6,846,910 - Zimmermann , et al. January 25, 2	2005-01-25
Fused heteroaryl derivatives Grant 6,838,457 - Hayakawa , et al. January 4, 2	2005-01-04
Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof Grant 6,830,924 - Chen , et al. December 14, 2	2004-12-14
Identification and functional characterization of a novel ribosomal S6 protein kinase Grant 6,830,909 - Gout , et al. December 14, 2	2004-12-14
Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy Grant 6,824,777 - Alitalo , et al. November 30, 2	2004-11-30
LAGE-1 tumor associated nucleic acids App 20040234541 - Lethe, Bernard ; et al.	2004-11-25
Staphylococcus aureus genes and polypeptides Grant 6,821,754 - Simpson , et al. November 23, 2	2004-11-23
Suppressor genes App 20040228866 - Lu, Xin	2004-11-18
Vascular endothelial growth factor C (VEGF-C) protein and gene mutants thereof, and uses thereof Grant 6,818,220 - Alitalo , et al. November 16, 2	2004-11-16
MAGE-C2 antigenic peptides and uses thereof App 20040214779 - Ma, Wenbin ; et al.	2004-10-28
Isolated peptides which bind to MHC class II molecules, and uses thereof Grant 6,800,730 - Tureci , et al. October 5, 2	2004-10-05
Colon cancer antigen panel Grant 6,794,501 - Chen , et al. September 21, 2	2004-09-21
Lage-1 tumor associated nucleic acids Grant 6,794,131 - Lethe , et al. September 21, 2	2004-09-21
In vivo stimulation of angiogenic activity Grant 6,793,918 - Enholm , et al. September 21, 2	2004-09-21
Vascular endothelial growth factor D(VEGF-D) antibodies and vectors, and methods of use App 20040175730 - Achen, Marc G. ; et al.	2004-09-09
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 6,774,226 - Jager , et al. August 10, 2	2004-08-10
Endogenous retrovirus tumor associated nucleic acids and antigens Grant 6,770,456 - Coulie , et al. August 3, 2	2004-08-03
Screening method for ligands with class II P13 kinase modulating activity Grant 6,770,467 - Domin , et al. August 3, 2	2004-08-03
Fused heteroaryl derivatives Grant 6,770,641 - Hayakawa , et al. August 3, 2	2004-08-03
Antibodies to truncated VEGF-D and uses thereof App 20040141917 - Achen, Marc G. ; et al.	2004-07-22
Screening for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3) Grant 6,764,820 - Ferrell , et al. July 20, 2	2004-07-20
Antibodies to truncated VEGF-D and uses thereof Grant 6,730,489 - Achen , et al. May 4, 2	2004-05-04
Stimulation of lymphatic growth with an FLT4 ligand Grant 6,730,658 - Alitalo , et al. May 4, 2	2004-05-04
Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof Grant 6,723,832 - Knuth , et al. April 20, 2	2004-04-20
Mage-A3 peptides presented by HLA class molecules Grant 6,716,809 - Schultz , et al. April 6, 2	2004-04-06
Tumor antigens and CTL clones isolated by a novel procedure Grant 6,710,172 - Chaux , et al. March 23, 2	2004-03-23
Composition and method for modulating vasculogenesis or angiogenesis App 20040053837 - Li, Xuri ; et al.	2004-03-18
Platelet-derived growth factor D Grant 6,706,687 - Eriksson , et al. March 16, 2	2004-03-16
Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use Grant 6,692,925 - Miyazono , et al. February 17, 2	2004-02-17
Growth factor Grant 6,689,580 - Achen , et al. February 10, 2	2004-02-10
Method for activating only the vascular endothelial growth factor receptor-3 and uses thereof Grant 6,689,352 - Achen , et al. February 10, 2	2004-02-10
Cancer associated antigens and uses therefor Grant 6,686,147 - Scanlan , et al. February 3, 2	2004-02-03
Isolated peptides derived from mage tumor rejection antigen precursors which complex with HLA-A2 molecules Grant 6,682,731 - Townsend , et al. January 27, 2	2004-01-27
Method For Identifying Individuals Suffering From A Cellular Abnormality Some Of Whose Abnormal Cells Present Complexes Of Hla-cw 1601/mage-1 Derived Peptides, And Methods For Treating Said Individuals Grant 6,680,056 - van der Bruggen , et al. January 20, 2	2004-01-20
Tumor associated peptide and uses thereof Grant 6,673,350 - Tureci , et al. January 6, 2	2004-01-06
Smad associating polypeptides Grant 6,673,570 - Itoh , et al. January 6, 2	2004-01-06
Method For Identifying Individuals Suffering From A Cellular Abnormality Some Of Whose Abnormal Cells Present Complexes Of Human Leukocyte Antigen Tyrosinase Derived Peptides, And Methods For Treating Said Individuals Grant 6,669,946 - Boon-Falleur , et al. December 30, 2	2003-12-30
Methods for detecting for the presence of tumor cells and for screening for anti-tumor agents Grant 6,670,125 - Li , et al. December 30, 2	2003-12-30
Isolated peptides which bind to HLA-B35 molecules, larger peptides which contain these, nucleic acid molecules encoding peptides, and uses thereof Grant 6,667,037 - Ooms , et al. December 23, 2	2003-12-23
Preventing secondary lymphedema with VEGF-D DNA App 20030228283 - Heinzerling, Lucie Margarete ; et al.	2003-12-11
Method for treating cancer using A33 specific antibodies and chemotherapeutic agents Grant 6,652,853 - Welt , et al. November 25, 2	2003-11-25
Imidazopyridine derivatives Grant 6,653,320 - Hayakawa , et al. November 25, 2	2003-11-25
Composition and method for modulating vasculogenesis or angiogenesis App 20030211994 - Li, Xuri ; et al.	2003-11-13
Method of treatment with IL-9 conjugate Grant 6,645,486 - Van Snick , et al. November 11, 2	2003-11-11
Receptor ligand VEGF-C Grant 6,645,933 - Alitalo , et al. November 11, 2	2003-11-11
Method for treating subjects by using BAGE tumor rejection antigen precursors or tumor rejection antigens Grant 6,638,512 - Boel , et al. October 28, 2	2003-10-28
Morphogenic protein-specific cell surface receptors and uses therefor Grant 6,632,618 - Dijke , et al. October 14, 2	2003-10-14
Cancer-testis antigens App 20030180298 - Old, Lloyd J. ; et al.	2003-09-25
Structurally modified peptides that are resistant to peptidase degradation Grant 6,623,740 - Gairin , et al. September 23, 2	2003-09-23
Tumor-associated antigen RHAMM App 20030170755 - Schmitt, Michael ; et al.	2003-09-11
Modified ion source targets for use in liquid maldi MS Grant 6,617,575 - Cramer September 9, 2	2003-09-09
Asthma associated factors as targets for treating atopic allergies including asthma and related disorders App 20030166150 - Renauld, Jean-Christophe ; et al.	2003-09-04
Fused heteroaryl derivatives Grant 6,608,056 - Hayakawa , et al. August 19, 2	2003-08-19
Fused heteroaryl derivatives Grant 6,608,053 - Hayakawa , et al. August 19, 2	2003-08-19
Method for identifying compounds that affect Smad7 binding Grant 6,605,443 - Nakao , et al. August 12, 2	2003-08-12
NY-ESO-1 peptide derivatives, and uses thereof Grant 6,605,711 - Valmori , et al. August 12, 2	2003-08-12
Delivery of proteins into eukaryotic cells with recombinant Yersinia Grant 6,602,506 - van der Bruggen , et al. August 5, 2	2003-08-05
Methods for diagnosing a disorder by assaying for MAGE-3 Grant 6,599,699 - Guagler , et al. July 29, 2	2003-07-29
Novel neuropilin/growth factor complexes and uses thereof App 20030125523 - Alitalo, Kari ; et al.	2003-07-03
Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use App 20030114658 - Achen, Marc G. ; et al.	2003-06-19
Breast cancer antigens App 20030108888 - Scanlan, Matthew J. ; et al.	2003-06-12
Isolated peptides consisting of amino acid sequences found in SSX or NY-ESO-1 molecules, which bind to HLA molecules Grant 6,548,064 - Tureci , et al. April 15, 2	2003-04-15
Method for identifying or isolating a molecule and molecules identified thereby Grant 6,531,280 - Pfreundschuh March 11, 2	2003-03-11
Truncated forms of NY-ESO-1 protein Grant 6,525,177 - Stockert , et al. February 25, 2	2003-02-25
Isolated nucleic acid molecule which codes for a 32 kDa protein having 11-CIS retinol dehydrogenase activity, and which associates with p63, a portion of a retinol binding protein receptor App 20030032169 - Eriksson, Ulf ; et al.	2003-02-13
Recombinant human anti-Lewis Y antibodies Grant 6,518,415 - Armour , et al. February 11, 2	2003-02-11
Neuropilin/growth factor complexes and uses thereof Grant 6,515,105 - Alitalo , et al. February 4, 2	2003-02-04
Stimulation of vascularization with VEGF-B App 20030008824 - Eriksson, Ulf ; et al.	2003-01-09
Methods for identifying antigens App 20030003485 - Uenaka, Akiko ; et al.	2003-01-02
Method for treating cancer by administering MAGE-derived peptides Grant 6,488,932 - Boon , et al. December 3, 2	2002-12-03
Lipid kinase Grant 6,482,623 - Vanhaesebroeck , et al. November 19, 2	2002-11-19
Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereof Grant 6,475,783 - Lucas , et al. November 5, 2	2002-11-05
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 6,448,073 - Jager , et al. September 10, 2	2002-09-10
Compositions of trail and DNA damaging drugs and uses thereof Grant 6,444,640 - Nagane , et al. September 3, 2	2002-09-03
Tumor antigens and CTL clones isolated by a novel procedure Grant 6,407,063 - Luiten , et al. June 18, 2	2002-06-18

Company Registrations

NCAGE Code	AR21N	LUDWIG INSTITUTE FOR CANCER RESEARCH
NCAGE Code	SKQ64	LUDWIG INSTITUTE FOR CANCER RESEARCH
CAGE Code	SKQ64	LUDWIG INSTITUTE FOR CANCER RESEARCH
CAGE Code	AR21N	LUDWIG INSTITUTE FOR CANCER RESEARCH

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.